Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 121-126
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.121
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.121
Table 1 Demographic and disease characteristics of the study population n (%)
Total | CD | UC | P value | |
n = 100 | n = 40 | n = 60 | ||
Sex | 0.198 | |||
Male | 54 (53.5) | 61.5% | 48.3% | |
Female | 46 (46.5) | 38.5% | 51.7% | |
Age (yr) (n = 97) | n = 38 | n = 59 | ||
18-35 | 39 (39.8) | 16 (41.0) | 23 (39.0) | 0.979 |
35-50 | 28 (28.6) | 11 (28.2) | 17 (28.8) | |
> 51 | 30 (31.6) | 11 (30.8) | 19 (32.2) | |
Smoking | 32 (33.0) | 43.2% | 26.7% | 0.092 |
Education | 0.673 | |||
Primary or less | 17.3% | 18.4% | 16.7% | |
Secondary | 49.0% | 42.1% | 53.3% | |
Tertiary or above | 33.7% | 39.5% | 30.0% | |
Employment status | 0.349 | |||
Government officials | 19.8% | 22.9% | 18.3% | |
Private employee | 44.8% | 44.4% | 45.0% | |
Self–employed | 4.2% | 8.3% | 1.7% | |
Unemployed | 31.3% | 25.0% | 35.0% | |
Family status | 0.822 | |||
Married | 62.6% | 59.0% | 65.0% | |
Unmarried | 32.3% | 35.9% | 30.0% | |
Divorced | 5.1% | 5.1% | 5.0% | |
Surgery | 20.9% | 36.1% | 11.7% | 0.004 |
Mean disease duration (yr) | 12.63% | 10.28% | 14.07% | 0.118 |
Treatment | 0.019 | |||
Immunosuppressive treatment | 65.0% | 55.0% | 71.7% | |
Immunosuppressive treatment + corticosteroids | 16.0% | 12.5% | 18.3% | |
Treatment with biologic agents | 19.0% | 32.5% | 10.0% | |
Treatment with corticosteroids | 22.0% | 17.5% | 25.0% | 0.375% |
Table 2 Short inflammatory bowel disease questionnaire score by dimension and type of disease (n = 100), mean (± SD) n (%)
Crohn’s disease | Ulcerative colitis | |
Physical dimension | 18.53 (7.55) | 19.52 (6.74) |
Psychological dimension | 10.68 (5.31) | 11.88 (4.49) |
Social dimension | 7.92 (3.03) | 8.63 (3.18) |
Overall SIBDQ | 33.79 (13.36) | 36.30 (11.39) |
Table 3 Physical Dimension scores of health-related quality of life in patients with Crohn’s disease and ulcerative colitis and their association to demographic parameters
Physical dimension | ||
Crohn’s disease, median | Ulcerative colitis, median | |
Gender | ||
Male | 3.3 | 4.2 |
Female | 3.5 | 3.4 |
Z | -0.015 | -2.274 |
P value | 0.988 | 0.023 |
Age | ||
< 35 | 3.1 | 4.0 |
35-50 | 3.8 | 3.2 |
> 50 | 3.8 | 4.2 |
χ2 | 1.232 | 7.767 |
P value | 0.540 | 0.021 |
Table 4 Psychological dimension scores of health-related quality of life in patients with Crohn’s disease and ulcerative colitis and their association to demographic parameters
Psychological dimension | ||
Crohn’s disease, median | Ulcerative colitis, median | |
Gender | ||
Male | 3.17 | 5.00 |
Female | 2.83 | 3.00 |
Z | -0.456 | -3.474 |
P value | 0.648 | 0.001 |
Age | ||
< 35 | 2.83 | 4.00 |
35-50 | 2.33 | 2.67 |
> 51 | 4.67 | 4.67 |
χ2 | 1.011 | 5.979 |
P value | 0.603 | 0.0503 |
Family status | ||
Married | 3.83 | 4.00 |
Single | 2.33 | 3.50 |
Z | 6.351 | -0.663 |
P value | 0.042 | 0.507 |
Table 5 Scores of health-related quality of life in patients with Crohn’s disease and ulcerative colitis in association to medication treatment
Medication | Median | Z | P value | |
Physical dimension | Biological factors | 5.00 | -1.484 | 0.138 |
Standard treatment | 3.20 | |||
Psychological dimension | Biological factors | 4.67 | -1.584 | 0.113 |
Standard treatment | 2.67 | |||
Social dimension | Biological factors | 5.00 | -2.004 | 0.045 |
Standard treatment | 3.25 |
- Citation: Tsoukka M, Jelastopulu E, Lavranos G, Charalambous G. Estimation of quality of life in Cypriot patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(1): 121-126
- URL: https://www.wjgnet.com/1007-9327/full/v23/i1/121.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i1.121